Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 1, 2007, Pages 21-28

  Safatle Ribeiro, Adriana V ^a,b   Ribeiro Jr , Ulysses ^a   Corbett, Carlos E P ^a   Iriya, Kiyoshi ^a   Kobata, Cristina H P ^a   Sakai, Paulo ^a   Yagi, Osmar K ^a   Pinto Jr , Paulo E ^a   Zilberstein, Bruno ^a   Gama Rodrigues, Joaquim ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Bcl 2; Carcinoid tumor; Enterochromaffin like cell tumor; Immunohistochemistry; Ki 67; Neuroendocrine tumor; p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CELL PROLIFERATION; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX RATIO; STOMACH CARCINOID;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; CELL PROLIFERATION; FEMALE; GASTROSCOPY; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846064623     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000250582.30737.bd     Document Type: Article

References (25)

1. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 2003; 99:23-32.
2. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996; 20:168-172.
3. Lubarsch O. Primary cancer of the ileum together with remarks about the simultaneous occurrence of cancer and tuberculosis [in German]. Virchows Arch (B) 1888; 3:280-317.
4. Akerstrom G. Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg 1996; 20:173-182.
5. Reinecke P, Borchard F. Pattern of gastric endocrine cells in microcarcinoids:an immunohistochemical study of 14 gastric biopsies. Virchows Arch 1996; 428:237-241.
6. Mello ES, Danilovic A, Dinato MCM, Segurado AVR, Alves VAF, Sakai P. Neuroendocrine tumors of the stomach and duodenum: a morphologic and immunohistochemical study of the different clinical and pathological presentations. Rev Med São Paulo 1999; 78:414-421.
7. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999; 116:532-542.
8. Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 1995; 90:338-352.
9. Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell G. Pharmacology and toxicology of omeprazole, with special reference to the effects on the gastric mucosa. Scand J Gastroenterol 1986; 118:31-38.
10. Havu N, Mattsson H, Ekman L, Carlsson K. ECL cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. Digestion 1990; 45:189-195.
11. Mattsson H, Havu N, Brutigam J, Carlsson K, Lundell L, Carlsson E. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffin-like carcinoids in the rat. Gastroenterology 1991; 110:311-319.
12. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formallin-fixed paraffin sections. J Pathol 1992; 168:357-363.
13. Hollstein MC, Sidranski D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253:49-53.
14. Joypaul BV, Newman EL, Hopwood D, Grant A, Qureshi S, Lane DP, et al. Expression of p53 protein in normal, dysplastic and malignant gastric mucosa: an immunohistochemical study. J Pathol 1993; 170:279-283.
15. Safatle-Ribeiro AV, Ribeiro U Jr, Reynolds JC, Gama-Rodrigues J, Iriya K, Kim R, et al. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and in the intact stomach. Cancer 1996; 78:2288-2299.
16. Lane DP. p53, guardian of the genome. Nature 1992; 358:15-16.
17. Azzoni C, Doglioni C, Viale G, Fave GD, De Boni M, Caruana P, et al. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol 1996; 20:433-441.
18. Clarke MR, Safatle-Ribeiro AV, Ribeiro U Jr, Sakai P, Reynolds JC. bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy. Mod Pathol 1997; 10:1021-1027.
19. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-580.
20. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13.715 carcinoid tumors. Cancer 2003; 97:934-959.
21. Rindi G. Clinicopathologic aspects of gastric neuroendocrine tumors. Am J Surg Pathol 1995; 19 (Suppl 1):S20-S29.
22. Ichikawa J, Tanabe S, Koizumi W, Kida Y, Imaizumi H, Hida Y, et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 2003; 35:197-202.
23. Baiocchi GI, Ronconi M, Villanacci V, Gambarotti M, Giulini SM. Type 1 gastric carcinoids: is the conservative approach always indicated? Endoscopy 2004; 36:457-465.
24. Peny MO, Donckier V, Gelin M, Haot J, Noel JC. Sporadic carcinoid of the stomach: a highly proliferative disease with a probable role for p53 protein dysregulation. Eur J Gastroenterol Hepatol 1999; 11:677-679.
25. Kawahara M, Kammori M, Kanauchi H, Noguchi C, Kuramoto S, Kaminishi M, et al. Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumors. Eur J Surg Oncol 2002; 28:140-146.